✦ LIBER ✦

Cost of Treating to a Modified European Atherosclerosis Society LDL-C Target

✍ Scribed by Dr D. G. Smith, S. J. Leslie, T. D. Szucs, S. McBride, L. M. Campbell, C. Calvo, J.-M. Lecerf, R. Fellin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparing the cost-effectiveness of ator

✍ Smith, D.G.; Berger, K.; Albright, J.; Johnson, K.; Nassen, K.; Seelhorst, G.; R 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 127 KB

PCV12: ACHIEVEMENT OF THE EUROPEAN ATHER

✍ J Morrell; S Edwards 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

PCV57 ESTIMATING THE NUMBER AND COST OF

✍ SL Kingslake 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

PCV29 COST-EFFECTIVENESS ANALYSIS OF ROS

✍ H Soto; D Mino; AC Polanco; G Gomez; P Miller 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PCV26 TREATING TO LOWER LDL-C TARGETS: E

✍ SL Kingslake 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

210: Safety and Efficacy of Atorvastatin

✍ John C. LaRosa; Scott M. Grundy; John J.P. Kastelein; John B. Kostis 📂 Article 📅 2007 🏛 Elsevier 🌐 English ⚖ 78 KB